Candriam S.C.A. Cuts Stake in UiPath, Inc. $PATH

Candriam S.C.A. lowered its holdings in shares of UiPath, Inc. (NYSE:PATH) by 69.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 149,307 shares of the company’s stock after selling 335,370 shares during the period. Candriam S.C.A.’s holdings in UiPath were worth $1,998,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the business. Covestor Ltd increased its holdings in shares of UiPath by 17.7% in the third quarter. Covestor Ltd now owns 6,522 shares of the company’s stock worth $87,000 after buying an additional 981 shares during the period. Rockefeller Capital Management L.P. grew its position in UiPath by 0.8% during the 2nd quarter. Rockefeller Capital Management L.P. now owns 123,329 shares of the company’s stock worth $1,579,000 after acquiring an additional 1,033 shares during the last quarter. State Board of Administration of Florida Retirement System increased its stake in UiPath by 0.4% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 313,946 shares of the company’s stock worth $4,019,000 after purchasing an additional 1,190 shares during the period. Advyzon Investment Management LLC increased its stake in UiPath by 7.7% in the 2nd quarter. Advyzon Investment Management LLC now owns 18,973 shares of the company’s stock worth $243,000 after purchasing an additional 1,355 shares during the period. Finally, Advisors Asset Management Inc. lifted its position in UiPath by 2.3% in the second quarter. Advisors Asset Management Inc. now owns 71,029 shares of the company’s stock valued at $909,000 after purchasing an additional 1,623 shares during the last quarter. 62.50% of the stock is owned by institutional investors.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 67,468 shares of the stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $16.10, for a total value of $1,086,234.80. Following the completion of the transaction, the chief financial officer directly owned 557,028 shares in the company, valued at $8,968,150.80. This trade represents a 10.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction dated Monday, January 26th. The stock was sold at an average price of $15.01, for a total transaction of $675,450.00. Following the sale, the chief executive officer directly owned 27,893,585 shares in the company, valued at $418,682,710.85. The trade was a 0.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 950,048 shares of company stock worth $15,881,744 over the last ninety days. Insiders own 23.19% of the company’s stock.

UiPath Stock Performance

Shares of NYSE:PATH opened at $11.19 on Friday. UiPath, Inc. has a 52-week low of $9.38 and a 52-week high of $19.84. The firm has a market capitalization of $5.98 billion, a P/E ratio of 26.63, a P/E/G ratio of 1.65 and a beta of 1.07. The stock has a 50 day moving average price of $15.44 and a 200-day moving average price of $13.98.

UiPath (NYSE:PATH) last released its quarterly earnings results on Wednesday, December 3rd. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.02. The company had revenue of $411.11 million for the quarter, compared to analyst estimates of $392.46 million. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The firm’s revenue was up 15.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.11 earnings per share. On average, equities analysts forecast that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on PATH. Barclays lifted their target price on shares of UiPath from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, January 12th. Royal Bank Of Canada set a $14.00 price objective on shares of UiPath in a research report on Wednesday. UBS Group reaffirmed a “neutral” rating on shares of UiPath in a research note on Thursday, December 4th. Truist Financial set a $17.00 target price on shares of UiPath in a report on Thursday, December 4th. Finally, TD Cowen restated a “hold” rating on shares of UiPath in a report on Thursday, December 4th. One analyst has rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $15.77.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.